- Turning the tide: From cervical cancer's grip to complete re... 2024-12-11
- Overexpression pattern, function, and clinical value of prot... 2024-12-11
- Nomogram for overall survival in ampullary adenocarcinoma us... 2024-12-11
- Programmed cell death 1 inhibitor sintilimab plus S-1 and ge... 2024-12-11
- Pancreatic cancer: Future challenges and new perspectives fo... 2024-12-11
World Journal of Clinical Oncology (WJCO, World J Clin Oncol) is a high-quality, online, open-access, single-blind peer-reviewed journal published by the Baishideng Publishing Group. WJCO accepts both solicited and unsolicited manuscripts. Articles published in WJCO are high-quality, clinical and basic, influential research articles by established academic authors as well as new researchers. The paramount objective of WJCO is to showcase and promote distinguished research in the field of oncology, to help advance development of this field. The types of articles published in WJCO include Editorial, Opinion Review, Frontier, Review, Minireview, Clinical Research, Basic Study, Systematic Review, Meta-analysis, Evidence-based Medicine, Field of Vision, Clinical Guidelines, Letter to the Editor, and Case Report. Submit here >>
- Jian-Hua Mao, BSc, MSc, PhD, Adjunct Professor, Senior Scientist, (E-mail: jhmao@lbl.gov) Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, United States
- Hiten RH Patel, BM BCh, BSc, FRCS, PhD, Professor, Surgical Oncologist, (E-mail: hrhpatel@hotmail.com) Department of Urology, University Hospital North Norway, Tromso 9038, Norway
- Stephen Safe, PhD, Professor, (E-mail: ssafe@cvm.tamu.edu) Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX 77845, United States
- Ken H Young, MD, PhD, Chief Physician, Director, Full Professor, (E-mail: ken.young@duke.edu) Hematopathology Division, Duke University Medical Center and Cancer Institute, Durham, NC 27710, United States
The 2024 edition of Journal Citation Reports® cites the 2023 journal impact factor (JIF) for WJCO as 2.6; JIF without journal self cites: 2.6; 5-year JIF: 2.7; JIF Rank: 175/322 in oncology; JIF Quartile: Q3; and 5-year JIF Quartile: Q3.